MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$2,516K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Accounts payable and accrued exp...
Right of use assets
Prepaid expenses and other curre...
Others
Negative Cash Flow Breakdown
Net loss
Operating lease liabilities
Accounts receivable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-3,164
-2,299
-2,426
-2,049
Depreciation and amortization expense
12
12
13
13
Decrease right of use assets
-
-147
-
226
Right of use assets
-
-
304
-
Grant receivable
-
70
-
-
Stock-based compensation
92
84
56
48
Prepaid expenses and other current assets
-160
90
-198
244
Deposits
19
-
7
-
Change in operating lease liabilities
-
-
301
-
Accounts receivable
35
-
-
-
Tax credit receivable
8
-15
193
-1,129
Right of use assets
-160
-
-
-
Accounts payable and accrued expenses
378
10
682
-320
Operating lease liabilities
-83
142
-
-75
Net cash used in operating activities
-2,516
-2,340
-1,736
-1,362
Purchases of property and equipment
-
-
0
12
Net cash used in investing activities
-
-
0
-12
Proceeds from the sale of common stock under atm
-
-
0
154
Proceeds from sale of common stock and warrants, net of transaction costs
-
-
1,032
4,183
Net cash provided by financing activities
-
-
1,032
4,337
Net decrease in cash and restricted cash
-2,516
-2,340
-704
2,963
Cash and restricted cash at beginning of period
4,760
7,100
7,804
9,935
Cash and restricted cash at end of period
2,244
4,760
7,100
7,804
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net decrease in cash
and restricted cash
-$2,516K
(50.61%↑ Y/Y)
Accounts payable and
accrued expenses
$378K
(161.66%↑ Y/Y)
Right of use assets
-$160K
Prepaid expenses and
other current assets
-$160K
(-8.11%↓ Y/Y)
Stock-based compensation
$92K
(-44.58%↓ Y/Y)
Depreciation and
amortization expense
$12K
(-73.91%↓ Y/Y)
Net cash used in
operating activities
-$2,516K
(50.61%↑ Y/Y)
Canceled cashflow
$802K
Net loss
-$3,164K
(27.36%↑ Y/Y)
Operating lease
liabilities
-$83K
(43.92%↑ Y/Y)
Accounts receivable
$35K
Deposits
$19K
(-67.80%↓ Y/Y)
Tax credit
receivable
$8K
(-98.13%↓ Y/Y)
Buy us a coffee
Cocrystal Pharma, Inc. (COCP)
Cocrystal Pharma, Inc. (COCP)